DNA X, Inc.
For the period ended Jun 30, 2026. Filed Aug 19, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 19, 2026
SONM$2.35+5.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
(IN THOUSANDS EXCEPT SHARE AMOUNTS)
| Common stock · Additional Paid-in · Accumulated · Stockholders’ | |||||
|---|---|---|---|---|---|
| For the Three Months Ended June 30, 2025 | Shares (*) | Amount | Capital | Deficit | Deficit |
| Balance at April 1, 2025 | 351,857 | $— | $282,071 | $(283,150) | $(1,079) |
| Issuance of common stock upon settlement of restricted stock units | 42,839 | — | — | — | — |
| Issuance of common stock, net of issuance costs | 179,657 | 4 | 5,411 | — | 5,415 |
| Stock-based compensation related to 2024 bonus accrual | — | — | 879 | — | 879 |
| Stock-based compensation | — | — | 926 | — | 926 |
| Impact of retroactively adjusted reverse stock split | — | (3) | 3 | — | — |
| Net income | — | — | — | (7,475) | (7,475) |
| Balance at June 30, 2025 | 574,353 | $1 | $289,290 | $(290,625) | $(1,334) |
| Common stock · Additional Paid-in · Accumulated · Stockholders’ | |||||
|---|---|---|---|---|---|
| For the Three Months Ended June 30, 2026 | Shares(*) | Amount | Capital | Deficit | Deficit |
| Balance at April 1, 2026 | 1,265,067 | $1 | $296,613 | $(297,597) | $(983) |
| Reclass redeemable common stock to permanent common stock at $4.315 on May 26, 2026 | 223,201 | — | 963 | (63) | 900 |
| Stock-based compensation | — | — | 98 | — | 98 |
| Net income | — | — | — | (1,247) | (1,247) |
| Balance at June 30, 2026 | 1,488,268 | $1 | $297,674 | $(298,907) | $(1,232) |
| Common stock · Additional Paid-in · Accumulated · Stockholders’ | |||||
|---|---|---|---|---|---|
| For the Six Months Ended June 30, 2025 | Shares (*) | Amount | Capital | Deficit | Deficit |
| Balance at January 1, 2025 | 276,881 | $— | $277,908 | $(283,608) | $(5,700) |
| Issuance of common stock upon settlement of restricted stock units | 42,956 | — | — | — | — |
| Issuance of common stock, net of issuance costs | 254,516 | 5 | 8,947 | — | 8,952 |
| Stock-based compensation related to 2024 bonus accrual | — | — | 1,215 | — | 1,215 |
| Stock-based compensation | — | — | 1,216 | — | 1,216 |
| Impact of retroactively adjusted reverse stock split | — | (4) | 4 | — | — |
| Net income | — | — | — | (7,017) | (7,017) |
| Balance at June 30, 2025 | 574,353 | $1 | $289,290 | $(290,625) | $(1,334) |
| Common stock · Additional Paid-in · Accumulated · Stockholders’ | |||||
|---|---|---|---|---|---|
| For the Six Months Ended June 30, 2026 | Shares(*) | Amount | Capital | Deficit | Deficit |
| Balance at January 1, 2026 | 1,265,067 | $1 | $296,309 | $(304,265) | $(7,955) |
| Change in fair value of redeemable common stock | — | — | — | 328 | 328 |
| Reclass redeemable common stock to permanent common stock at $4.315 on May 26, 2026 | 223,201 | — | 963 | (63) | 900 |
| Stock-based compensation | — | — | 402 | — | 402 |
| Net income | — | — | — | 5,093 | 5,093 |
| Balance at June 30, 2026 | 1,488,268 | $1 | $297,674 | $(298,907) | $(1,232) |
| (*) | Adjusted retroactively to reflect the 1-for-18 reverse stock split that became effective on October 28, 2025, see Note 1. |
|---|
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.